Report Detail

Request for Sample of this report

Pharma & Healthcare Global Pet Biological Products Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744614
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 115 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pet Biological Products market size was valued at US$ 1349 million in 2025 and is forecast to a readjusted size of US$ 2271 million by 2032 with a CAGR of 7.8% during review period.
Veterinary biological products are made of natural or artificially modified microorganisms, parasites, biological toxins, biological tissues and metabolites, etc. Medicines for the prevention, treatment, and diagnosis of animal diseases or for changing animal production performance.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 502%.
This report is a detailed and comprehensive analysis for global Pet Biological Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pet Biological Products market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pet Biological Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pet Biological Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pet Biological Products market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pet Biological Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pet Biological Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pet Biological Products market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Drug
Vaccine
Market segment by Application
Cat
Dog
Reptile
Other
Major players covered
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pet Biological Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pet Biological Products, with price, sales quantity, revenue, and global market share of Pet Biological Products from 2021 to 2026.
Chapter 3, the Pet Biological Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Biological Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pet Biological Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pet Biological Products.
Chapter 14 and 15, to describe Pet Biological Products sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pet Biological Products Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Drug
    • 1.3.3 Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pet Biological Products Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cat
    • 1.4.3 Dog
    • 1.4.4 Reptile
    • 1.4.5 Other
  • 1.5 Global Pet Biological Products Market Size & Forecast
    • 1.5.1 Global Pet Biological Products Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pet Biological Products Sales Quantity (2021-2032)
    • 1.5.3 Global Pet Biological Products Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Zoetis
    • 2.1.1 Zoetis Details
    • 2.1.2 Zoetis Major Business
    • 2.1.3 Zoetis Pet Biological Products Product and Services
    • 2.1.4 Zoetis Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Zoetis Recent Developments/Updates
  • 2.2 Boehringer Ingelheim
    • 2.2.1 Boehringer Ingelheim Details
    • 2.2.2 Boehringer Ingelheim Major Business
    • 2.2.3 Boehringer Ingelheim Pet Biological Products Product and Services
    • 2.2.4 Boehringer Ingelheim Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Pet Biological Products Product and Services
    • 2.3.4 Merck Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Elanco
    • 2.4.1 Elanco Details
    • 2.4.2 Elanco Major Business
    • 2.4.3 Elanco Pet Biological Products Product and Services
    • 2.4.4 Elanco Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Elanco Recent Developments/Updates
  • 2.5 Virbac
    • 2.5.1 Virbac Details
    • 2.5.2 Virbac Major Business
    • 2.5.3 Virbac Pet Biological Products Product and Services
    • 2.5.4 Virbac Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Virbac Recent Developments/Updates
  • 2.6 Dechra Veterinary Products
    • 2.6.1 Dechra Veterinary Products Details
    • 2.6.2 Dechra Veterinary Products Major Business
    • 2.6.3 Dechra Veterinary Products Pet Biological Products Product and Services
    • 2.6.4 Dechra Veterinary Products Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Dechra Veterinary Products Recent Developments/Updates
  • 2.7 Ceva
    • 2.7.1 Ceva Details
    • 2.7.2 Ceva Major Business
    • 2.7.3 Ceva Pet Biological Products Product and Services
    • 2.7.4 Ceva Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ceva Recent Developments/Updates
  • 2.8 Vetoquinol
    • 2.8.1 Vetoquinol Details
    • 2.8.2 Vetoquinol Major Business
    • 2.8.3 Vetoquinol Pet Biological Products Product and Services
    • 2.8.4 Vetoquinol Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Vetoquinol Recent Developments/Updates
  • 2.9 Ouro Fino Saude
    • 2.9.1 Ouro Fino Saude Details
    • 2.9.2 Ouro Fino Saude Major Business
    • 2.9.3 Ouro Fino Saude Pet Biological Products Product and Services
    • 2.9.4 Ouro Fino Saude Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ouro Fino Saude Recent Developments/Updates
  • 2.10 Norbrook
    • 2.10.1 Norbrook Details
    • 2.10.2 Norbrook Major Business
    • 2.10.3 Norbrook Pet Biological Products Product and Services
    • 2.10.4 Norbrook Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Norbrook Recent Developments/Updates
  • 2.11 Jindun
    • 2.11.1 Jindun Details
    • 2.11.2 Jindun Major Business
    • 2.11.3 Jindun Pet Biological Products Product and Services
    • 2.11.4 Jindun Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Jindun Recent Developments/Updates
  • 2.12 Wuhan chopperlvya
    • 2.12.1 Wuhan chopperlvya Details
    • 2.12.2 Wuhan chopperlvya Major Business
    • 2.12.3 Wuhan chopperlvya Pet Biological Products Product and Services
    • 2.12.4 Wuhan chopperlvya Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Wuhan chopperlvya Recent Developments/Updates
  • 2.13 CAHIC
    • 2.13.1 CAHIC Details
    • 2.13.2 CAHIC Major Business
    • 2.13.3 CAHIC Pet Biological Products Product and Services
    • 2.13.4 CAHIC Pet Biological Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 CAHIC Recent Developments/Updates

3 Competitive Environment: Pet Biological Products by Manufacturer

  • 3.1 Global Pet Biological Products Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pet Biological Products Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pet Biological Products Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pet Biological Products by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pet Biological Products Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pet Biological Products Manufacturer Market Share in 2025
  • 3.5 Pet Biological Products Market: Overall Company Footprint Analysis
    • 3.5.1 Pet Biological Products Market: Region Footprint
    • 3.5.2 Pet Biological Products Market: Company Product Type Footprint
    • 3.5.3 Pet Biological Products Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pet Biological Products Market Size by Region
    • 4.1.1 Global Pet Biological Products Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pet Biological Products Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pet Biological Products Average Price by Region (2021-2032)
  • 4.2 North America Pet Biological Products Consumption Value (2021-2032)
  • 4.3 Europe Pet Biological Products Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pet Biological Products Consumption Value (2021-2032)
  • 4.5 South America Pet Biological Products Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pet Biological Products Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pet Biological Products Sales Quantity by Type (2021-2032)
  • 5.2 Global Pet Biological Products Consumption Value by Type (2021-2032)
  • 5.3 Global Pet Biological Products Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pet Biological Products Sales Quantity by Application (2021-2032)
  • 6.2 Global Pet Biological Products Consumption Value by Application (2021-2032)
  • 6.3 Global Pet Biological Products Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pet Biological Products Sales Quantity by Type (2021-2032)
  • 7.2 North America Pet Biological Products Sales Quantity by Application (2021-2032)
  • 7.3 North America Pet Biological Products Market Size by Country
    • 7.3.1 North America Pet Biological Products Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pet Biological Products Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pet Biological Products Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pet Biological Products Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pet Biological Products Market Size by Country
    • 8.3.1 Europe Pet Biological Products Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pet Biological Products Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pet Biological Products Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pet Biological Products Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pet Biological Products Market Size by Region
    • 9.3.1 Asia-Pacific Pet Biological Products Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pet Biological Products Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pet Biological Products Sales Quantity by Type (2021-2032)
  • 10.2 South America Pet Biological Products Sales Quantity by Application (2021-2032)
  • 10.3 South America Pet Biological Products Market Size by Country
    • 10.3.1 South America Pet Biological Products Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pet Biological Products Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pet Biological Products Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pet Biological Products Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pet Biological Products Market Size by Country
    • 11.3.1 Middle East & Africa Pet Biological Products Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pet Biological Products Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pet Biological Products Market Drivers
  • 12.2 Pet Biological Products Market Restraints
  • 12.3 Pet Biological Products Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pet Biological Products and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pet Biological Products
  • 13.3 Pet Biological Products Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pet Biological Products Typical Distributors
  • 14.3 Pet Biological Products Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pet Biological Products. Industry analysis & Market Report on Pet Biological Products is a syndicated market report, published as Global Pet Biological Products Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pet Biological Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo